JP2018527324A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527324A5
JP2018527324A5 JP2018503213A JP2018503213A JP2018527324A5 JP 2018527324 A5 JP2018527324 A5 JP 2018527324A5 JP 2018503213 A JP2018503213 A JP 2018503213A JP 2018503213 A JP2018503213 A JP 2018503213A JP 2018527324 A5 JP2018527324 A5 JP 2018527324A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
aryl
thiazole
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018503213A
Other languages
English (en)
Japanese (ja)
Other versions
JP6867998B2 (ja
JP2018527324A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/067506 external-priority patent/WO2017017004A1/en
Publication of JP2018527324A publication Critical patent/JP2018527324A/ja
Publication of JP2018527324A5 publication Critical patent/JP2018527324A5/ja
Application granted granted Critical
Publication of JP6867998B2 publication Critical patent/JP6867998B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018503213A 2015-07-24 2016-07-22 ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物 Active JP6867998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306213 2015-07-24
EP15306213.8 2015-07-24
PCT/EP2016/067506 WO2017017004A1 (en) 2015-07-24 2016-07-22 Substituted hydrophobic benzene sulfonamide thiazole compounds for use in treating cancer

Publications (3)

Publication Number Publication Date
JP2018527324A JP2018527324A (ja) 2018-09-20
JP2018527324A5 true JP2018527324A5 (enExample) 2020-12-17
JP6867998B2 JP6867998B2 (ja) 2021-05-12

Family

ID=53758161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503213A Active JP6867998B2 (ja) 2015-07-24 2016-07-22 ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物

Country Status (4)

Country Link
US (2) US10815207B2 (enExample)
EP (1) EP3325452B1 (enExample)
JP (1) JP6867998B2 (enExample)
WO (1) WO2017017004A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113056305A (zh) 2018-11-23 2021-06-29 格雷沃尔夫治疗有限公司 化合物
CN115477626B (zh) * 2021-06-16 2024-08-02 上海璃道医药科技有限公司 N-取代苯基磺酰胺类化合物及其用途
EP4201928A1 (en) 2021-12-21 2023-06-28 Institut National de la Santé et de la Recherche Médicale (INSERM) Benzene sulfonamide thiazole compounds and their use for the treatment of cancers
JP2025536252A (ja) * 2022-10-20 2025-11-05 アンセルム(アンスティチュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル) 癌治療のための併用療法
EP4635480A1 (en) 2024-04-19 2025-10-22 Biper Therapeutics SAS Compositions comprising a benzene sulfonamide thiazole compound
WO2025219595A1 (en) * 2024-04-19 2025-10-23 Biper Therapeutics Method for combination treatments using alkynylbenzenesulphonamides for cancer therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2817219B2 (ja) * 1988-09-08 1998-10-30 武田薬品工業株式会社 カルバジン酸誘導体、その製造法及び製剤
US7163952B2 (en) 2001-12-03 2007-01-16 Japan Tobacco Inc. Azole compound and medicinal use thereof
CA2633569A1 (en) 2005-12-12 2007-06-21 Genelabs Technologies, Inc. N-(5-membered heteroaromatic ring)-amido anti-viral compounds
WO2008027912A2 (en) 2006-08-28 2008-03-06 Dan Theodorescu Prediction of an agent's or agents' activity across different cells and tissue types
NZ582485A (en) 2007-07-17 2012-05-25 Rigel Pharmaceuticals Inc Cyclic amine substituted pyrimidinediamines as pkc inhibitors
WO2009146013A1 (en) * 2008-03-31 2009-12-03 Georgetown University Myosin light chain phosphatase inhibitors
WO2014072486A1 (en) * 2012-11-09 2014-05-15 INSERM (Institut National de la Santé et de la Recherche Médicale) New benzene sulfonamide thiazole compounds

Similar Documents

Publication Publication Date Title
JP2018527324A5 (enExample)
JP2009531322A5 (enExample)
JP2015537020A5 (enExample)
JP2017537940A5 (enExample)
JP2013010793A5 (enExample)
HRP20201985T1 (hr) Piridonski spoj kao c-met inhibitor
JP2018522866A5 (enExample)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2016514159A5 (enExample)
RU2011124304A (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2017523169A5 (enExample)
EA201990902A1 (ru) Ингибиторы тирозинкиназы брутона
JP2013010792A5 (enExample)
JP2009504763A5 (enExample)
JP2016531126A5 (enExample)
JP2017508782A5 (enExample)
JP2015532295A5 (enExample)
JP2017531619A5 (enExample)
JP2020507589A5 (enExample)
JP2019510034A5 (enExample)
JP2016503797A5 (enExample)
JP2017141277A5 (enExample)
JP2009511508A5 (enExample)
JP2014500265A5 (enExample)
RU2017101829A (ru) Пиразоловые соединения в качестве модуляторов fshr и пути их применения